Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Roger K. Cady, James Banks$suffix/text()$suffix/text(), Beverly A. Jones & John Campbell. (2009) Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination. Current Medical Research and Opinion 25:11, pages 2711-2721.
Read now
Read now
Carlo Lovati, Domenico D’Amico & Pierluigi Bertora. (2009) Allodynia in migraine: frequent random association or unavoidable consequence?. Expert Review of Neurotherapeutics 9:3, pages 395-408.
Read now
Read now
Articles from other publishers (20)
Paulo Sergio Faro Santos, Eliana Meire Melhado, Alexandre Ottoni Kaup, Aline Turbino Neves Martins da Costa, Célia Aparecida de Paula Roesler, Élcio Juliato Piovesan, Elder Machado Sarmento, Giselle Oliveira Martins Theotonio, Henrique Carneiro de Campos, Ida Fortini, Jano Alves de Souza, Jayme Antunes Maciel Júnior, João Batista Alves Segundo, João José Freitas de Carvalho, José Geraldo Speziali, Leandro Cortoni Calia, Liselotte Menke Barea, Luiz Paulo Queiroz, Marcio Nattan Portes Souza, Marcos Ravi Cerqueira Ferreira Figueiredo, Maria Eduarda Nobre de Magalhães Costa, Mário Fernando Prieto Peres, Mauro Eduardo Jurno, Patrícia Machado Peixoto, Pedro André Kowacs, Pedro Augusto Sampaio Rocha-Filho, Pedro Ferreira Moreira Filho, Raimundo Pereira Silva-Neto & Yara Dadalti Fragoso. (2022) Consensus of the Brazilian Headache Society (SBCe) for prophylactic treatment of episodic migraine: part II. Arquivos de Neuro-Psiquiatria 80:09, pages 953-969.
Crossref
Crossref
Ladislav Pazdera, Joshua M Cohen, Xiaoping Ning, Verena Ramirez Campos, Ronghua Yang & Patricia Pozo-Rosich. (2021) Fremanezumab for the Preventive Treatment of Migraine: Subgroup Analysis by Number of Prior Preventive Treatments with Inadequate Response. Cephalalgia 41:10, pages 1075-1088.
Crossref
Crossref
Matthew V. Purbaugh & Amrita-Amanda D. Vuppala. 2021. Controversies in Neuro-Ophthalmic Management. Controversies in Neuro-Ophthalmic Management
209
223
.
Simona Sacco, Mark Braschinsky, Anne Ducros, Christian Lampl, Patrick Little, Antoinette Maassen van den Brink, Patricia Pozo-Rosich, Uwe Reuter, Elena Ruiz de la Torre, Margarita Sanchez Del Rio, Alexandra J. Sinclair, Zaza Katsarava & Paolo Martelletti. (2020) European headache federation consensus on the definition of resistant and refractory migraine. The Journal of Headache and Pain 21:1.
Crossref
Crossref
Abouch V. Krymchantowski, Ana Gabriela Ferreira Krymchantowski & Carla da Cunha Jevoux. (2018) Medication-overuse headache. Retrospective comparison of preventive treatments. Arquivos de Neuro-Psiquiatria 76:10, pages 668-673.
Crossref
Crossref
Leda Marina Pomes, Giovanna Gentile, Maurizio Simmaco, Marina Borro & Paolo Martelletti. (2018) Tailoring Treatment in Polymorbid Migraine Patients through Personalized Medicine. CNS Drugs 32:6, pages 559-565.
Crossref
Crossref
Marcelo E. Bigal. 2013. Headache. Headache
140
152
.
Elliott Schulman. (2013) Refractory Migraine – A Review. Headache: The Journal of Head and Face Pain 53:4, pages 599-613.
Crossref
Crossref
Domenico D’Amico. (2012) Controversies in migraine: monotherapy. Neurological Sciences 33:S1, pages 141-145.
Crossref
Crossref
Ning Luo, Wei Di, Aiwu Zhang, Ying Wang, Minghui Ding, Weiwei Qi, Yingting Zhu, Mark W. Massing & Yannan Fang. (2012) A Randomized, One-Year Clinical Trial Comparing the Efficacy of Topiramate, Flunarizine, and a Combination of Flunarizine and Topiramate in Migraine Prophylaxis. Pain Medicine 13:1, pages 80-86.
Crossref
Crossref
Abouch Valenty Krymchantowski, Carla da Cunha Jevoux & Marcelo E. Bigal. (2011) Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders. The Journal of Headache and Pain 13:1, pages 53-59.
Crossref
Crossref
Martin J. Brodie, Athanasios Covanis, Antonio Gil-Nagel, Holger Lerche, Emilio Perucca, Graeme J. Sills & H. Steve White. (2011) Antiepileptic drug therapy: Does mechanism of action matter?. Epilepsy & Behavior 21:4, pages 331-341.
Crossref
Crossref
John-Kenneth Sake, David Hebert, Jouko Isojärvi, Pamela Doty, Marc De Backer, Kendra Davies, Andrea Eggert-Formella & James Zackheim. (2010) A Pooled Analysis of Lacosamide Clinical Trial Data Grouped by Mechanism of Action of Concomitant Antiepileptic Drugs. CNS Drugs 24:12, pages 1055-1068.
Crossref
Crossref
Abouch V. Krymchantowski, Carla Jevoux & Pedro Ferreira Moreira. (2010) An Open Pilot Study Assessing the Benefits of Quetiapine for the Prevention of Migraine Refractory to the Combination of Atenolol, Nortriptyline, and Flunarizine: Table 1. Pain Medicine 11:1, pages 48-52.
Crossref
Crossref
. (2009) Memantine in the Preventive Treatment for Migraine and Refractory Migraine. Headache: The Journal of Head and Face Pain 49:3, pages 481-482.
Crossref
Crossref
Angelo SghirlanzoniGennaro Bussone & Domenico D’Amico. 2010. Terapia delle malattie neurologiche. Terapia delle malattie neurologiche
217
248
.
Abouch Valenty Krymchantowski & Carla da Cunha Jevoux. (2008) Migraine prevention trials and optimized acute therapy: Translating lessons learned into clinical practice. Current Pain and Headache Reports 12:3, pages 220-223.
Crossref
Crossref
Domenico D’Amico, Massimo Leone, Licia Grazzi & Gennaro Bussone. (2008) When should “chronic migraine” patients be considered “refractory” to pharmacological prophylaxis?. Neurological Sciences 29:S1, pages 55-58.
Crossref
Crossref
Abouch V Krymchantowski & Carla Jevoux. (2008) Quetiapine for the prevention of migraine refractory to the combination of atenolol + nortriptyline + flunarizine: an open pilot study. Arquivos de Neuro-Psiquiatria 66:3b, pages 615-618.
Crossref
Crossref
Abouch Valenty Krymchantowski & Carla da Cunha Jevoux. (2007) Combining different classes of drugs for the acute treatment of migraine. Drug Development Research 68:7, pages 419-423.
Crossref
Crossref